| Basics |
| Company: |
Neumora Therapeutics, Inc. |
| IPO Date: |
September 15, 2023 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$290.81M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.38 | 3.27%
|
| Avg Daily Range (30 D): |
$0.06 | 2.87%
|
| Avg Daily Range (90 D): |
$0.29 | 3.34%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.91M |
| Avg Daily Volume (30 D): |
2.45M |
| Avg Daily Volume (90 D): |
2.23M |
| Trade Size |
| Avg Trade Size (Sh.): |
118 |
| Avg Trade Size (Sh.) (30 D): |
202 |
| Avg Trade Size (Sh.) (90 D): |
154 |
| Institutional Trades |
| Total Inst.Trades: |
282 |
| Avg Inst. Trade: |
$1.83M |
| Avg Inst. Trade (30 D): |
$.79M |
| Avg Inst. Trade (90 D): |
$1.46M |
| Avg Inst. Trade Volume: |
.18M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.34M |
| Avg Closing Trade (30 D): |
$.81M |
| Avg Closing Trade (90 D): |
$1.51M |
| Avg Closing Volume: |
239.09K |
|
|
|
|
| News |
Feb 20, 2025 @ 10:41 PM
NMRA Investors are Suing Neumora Therapeutics, Inc...
Source: N/A
|
Feb 19, 2025 @ 11:11 PM
ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encoura...
Source: N/A
|
Feb 18, 2025 @ 9:00 PM
NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Feb 18, 2025 @ 6:01 PM
Lowey Dannenberg Notifies Neumora Therapeutics, In...
Source: N/A
|
Feb 18, 2025 @ 1:10 AM
Kessler Topaz Meltzer & Check, LLP - Class Action ...
Source: Kessler Topaz Meltzer & Check, Llp
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-1.2
|
$-.45
|
$-.37
|
|
Diluted EPS
|
$-1.2
|
$-.45
|
$-.37
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -293.7M
|
$ -72.55M
|
$ -58.7M
|
|
Operating Income / Loss
|
$ -314.55M
|
$ -76.65M
|
$ -63.82M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -136.57M
|
$ 125.04M
|
$ -32.25M
|
|
PE Ratio
|
|
|
|
|
